Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 5:23 pm Purchase |
2024-06-28 | 13G | DiaMedica Therapeutics Inc. DMAC |
DIALECTIC CAPITAL MANAGEMENT LP | 2,205,795 5.200% |
2,205,795 (New Position) |
Filing History |
| 2023-06-27 4:12 pm Purchase |
2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC |
TomEnterprise AB | 4,326,435 11.400% |
1,470,588 (+51.49%) |
Filing History |
| 2023-06-27 4:11 pm Purchase |
2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC |
TRILL AB | 4,021,608 10.600% |
1,470,588 (+57.65%) |
Filing History |
| 2023-06-23 5:13 pm Purchase |
2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 4,558,823 12.000% |
2,058,823 (+82.35%) |
Filing History |
| 2023-02-13 10:37 am Purchase |
2022-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYNCH TIMOTHY P | 100,259 0.400% |
100,259 (New Position) |
Filing History |
| 2023-01-13 4:46 pm Purchase |
2022-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 2,500,000 9.500% |
850,947 (+51.60%) |
Filing History |
| 2022-12-06 4:06 pm Purchase |
2022-07-08 | 13G | DiaMedica Therapeutics Inc. DMAC |
TomEnterprise Private AB | 2,855,847 10.800% |
2,855,847 (New Position) |
Filing History |
| 2022-07-12 1:24 pm Purchase |
2022-07-08 | 13G | DiaMedica Therapeutics Inc. DMAC |
TomEnterprise AB | 2,855,847 10.800% |
304,827 (+11.95%) |
Filing History |
| 2022-05-27 4:44 pm Purchase |
2022-04-20 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 1,649,053 6.200% |
1,649,053 (New Position) |
Filing History |
| 2022-02-15 2:25 pm Sale |
2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,071,970 4.100% |
-308,296 (-22.34%) |
Filing History |
| 2022-02-11 2:17 pm Purchase |
2021-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
Stonepine Capital Management, LLC | 1,394,929 5.300% |
244,670 (+21.27%) |
Filing History |
| 2021-10-08 4:17 pm Purchase |
2021-09-28 | 13G | DiaMedica Therapeutics Inc. DMAC |
TRILL AB | 2,551,020 9.600% |
2,551,020 (New Position) |
Filing History |
| 2021-10-08 4:14 pm Purchase |
2021-09-28 | 13G | DiaMedica Therapeutics Inc. DMAC |
TomEnterprise AB | 2,551,020 9.600% |
2,551,020 (New Position) |
Filing History |
| 2021-10-06 4:19 pm Purchase |
2021-09-26 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,380,266 5.200% |
1,380,266 (New Position) |
Filing History |
| 2021-02-12 5:04 pm Purchase |
2020-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
Stonepine Capital Management, LLC | 1,150,259 6.100% |
350,259 (+43.78%) |
Filing History |
| 2020-12-23 4:31 pm Sale |
2020-12-15 | 13G | DiaMedica Therapeutics Inc. DMAC |
Xiao Zhenyu | 936,805 4.999% |
-78,295 (-7.71%) |
Filing History |